IGIM
SGMO

I.G. Investment Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

I.G. Investment Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-240,000
Closed -$1.11M – 675
2016
Q3 		$1.11M Buy
+240,000
New +$1.22M ﹤0.01% 628

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FC
FIC Capital New York $262M AUM 34.37% 1-Year Est. Return

I.G. Investment Management's SGMO Position: Q4 2016 in Review

I.G. Investment Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2016, closing a stake of 240,000 shares — an estimated $1.11M sold.

I.G. Investment Management first reported a position in SGMO in Q3 2016 and held it in 1 quarter. The position peaked at $1.11M in Q3 2016. 126 funds tracked by Wall St. Rank hold SGMO as of Q4 2016.

  • I.G. Investment Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2016 after selling out during the quarter.
  • I.G. Investment Management sold 240,000 SANGAMO THERAPEUTICS INC shares in Q4 2016, an estimated $1.11M.
  • I.G. Investment Management first reported a position in SANGAMO THERAPEUTICS INC in Q3 2016 and held it in 1 quarter.
  • I.G. Investment Management's SANGAMO THERAPEUTICS INC position peaked at $1.11M in Q3 2016.
  • 126 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2016.

Based on I.G. Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.